Diarrhea occurs commonly among persons with HIV infection: the reported prevalence in developed countries ranges from 42% to 90% [1, 2] . Diarrheal illness adversely affects quality of life [3, 4] and is associated with decreased survival after AIDS has developed [5] . Cumulative risk for chronic diarrhea after development of AIDS increases from 48.5% in the first year to 95.6% in the third year [1] . Among persons with HIV infection, 40%-80% of diarrheal illnesses have an identifiable infectious cause, and a bacterial etiology is common [1, [6] [7] [8] [9] [10] .
No studies have examined the annual incidences of bacterial diarrhea before and during the HAART era in a large cohort of persons with HIV infection. There are few data characterizing the incidence of bacterial diarrheal illness with respect to stage of HIV disease. Therefore, we analyzed diarrheal illness with a confirmed bacterial cause in a large cohort of HIV-infected adults. We also examined the annual incidence rates (stratified according to the stage of HIV disease) of bacterial diarrhea.
METHODS

Study design.
We used data from the Adult/Adolescent Spectrum of HIV Disease (ASD) Project, a retrospective cohort study initiated in 1990 as a supplement to the national HIV/AIDS surveillance system. The ASD Project was sponsored by the Centers for Disease Control and Prevention (CDC) in collaboration with 11 state and local health departments and was approved by the human subjects review boards of the CDC and all participating health departments. A more detailed description of the ASD Project has been published elsewhere [11] . Data were abstracted from participant medical records for the 1-year period before their enrollment date and for every 6-month period thereafter until death, loss to follow-up, or 31 December 2003. Data abstracted included clinical diagnoses, laboratory values (including microbiological findings and CD4 + cell counts), and medical treatment related to HIV infection and other illnesses. We excluded 2 ASD Project areas from our analysis because of delayed and incomplete reporting. More than 100 facilities in the 9 areas participated in the study, including hospitals, outpatient offices, and emergency departments. We analyzed medical data from 1992 through 2002; this period included the most complete reporting from the sites involved in the present analysis and also included data for patients enrolled before and patients enrolled before and after the introduction of HAART.
Definitions. We considered a case of diarrhea to be infectious if the episode was accompanied by a laboratory-generated microbiological diagnosis or by physician documentation of a causative agent in the medical record. For this analysis we included only diagnoses associated with organisms that have been previously described as bacterial causes of diarrheal illness. (Bacterial enteric organisms that were considered to be causes of diarrheal disease in the general population and/or persons with HIV infection were as follows: Clostridium species, Salmonella species, Campylobacter species, Shigella species, Mycobacterium avium complex [MAC], intoxication-associated Staphylococcus aureus, Aeromonas species, Vibrio species, Yersinia species, and Edwardsiella tarda [1, 2, [12] [13] [14] [15] [16] .) The ASD Project did not systematically record the microbiological methods used to identify organisms. For diarrhea attributed to S. aureus, we queried a random subset of reporting laboratories, all of which made the identifications using toxin assays. Because the ASD Project was unable to reliably record diagnoses of diarrheagenic Escherichia coli, diarrheal illnesses caused by this species were not included in our analysis. If multiple organisms were identified from a single episode of diarrheal illness, each organism was counted individually for tabulation of pathogen frequencies. Such illness episodes were counted only once in calculations of the incidence of bacterial diarrhea. If Clostridium difficile was found concomitantly with another bacterial pathogen during the same illness episode, that episode could not be accurately categorized. Episodes that could not be categorized were excluded from the incidence calculations. To limit the potential effect of persistent diarrheal illness on incidence estimates, if bacterial diarrhea was identified during successive 6-month abstraction periods, only the illness from the first of the successive periods was retained in the analysis.
The stage of HIV disease was defined according to the 1993 CDC guidelines [17] . We classified a person into 1 of the following 3 mutually exclusive categories: clinical AIDS (any previous diagnosis of at least 1 AIDS-defining opportunistic infection, regardless of CD4 + cell count), immunologic AIDS (any previous CD4 + cell count of !200 cells/mL or a CD4 + cell percentage of !14% but no clinical AIDS), or HIV infection without AIDS (HIV infection not defined as immunologic or clinical AIDS). Data from abstraction periods during which a definitive classification into one of these categories was not possible (e.g., CD4
+ cell count was not reported) were excluded from analysis of incidence rates.
Outcome measures. We calculated incidence rates of diarrhea per 1000 person-years and incidence rate ratios according to stage of HIV disease. For comparison purposes, we separately analyzed reports of C. difficile-associated diarrhea (CDAD) and reports of diarrhea due to other bacteria. Changes in rates were examined using logistic regression analysis (Proc Genmod; SAS Institute), with year of diagnosis as the regressor and 1992 as the referent year. The regression model controlled for repeated observations of the same person over time, with results expressed as an OR with a 95% CI. A change was considered to be significant if the 95% CI excluded 1.00.
RESULTS
We analyzed data for 44,778 persons with a total follow-up duration of 115,979 person-years (mean follow-up duration, 2.6 years per person). Most of the participants were white or black, non-Hispanic men aged 30-44 years (table 1) . Of 11,320 episodes of diarrheal illness reported during the analysis period, 1091 (9.6%) had at least 1 bacterial organism listed as a causative agent. The total number of bacterial organisms identified during these diarrhea episodes was 1115. The mean annual incidence of bacterial diarrhea from 1992 through 2002 was 7.2 cases per 1000 person-years. Frequencies of bacterial pathogens during diarrhea episodes. C. difficile was the most commonly identified bacterial pathogen among diarrhea episodes, accounting for 53.6% (598 of 1115) of all bacterial agents reported (table 2) . Shigella, Campylobacter, and Salmonella organisms accounted for 14.0%, 13.8%, and 7.4%, of bacterial agents reported, respectively: species or serotype was not reported for most cases of diarrhea caused by these organisms. A mixture of other bacteria was identified in the remaining cases. Two bacterial organisms of a different genus were identified as the cause of 21 episodes of bacterial diarrhea. Of these 21 episodes, 15 had both C. difficile and another type of bacteria.
Incidence of bacterial diarrhea, by stage of HIV disease. For the stratified incidence analyses, we excluded 15 episodes of concomitant CDAD and other bacterial diarrhea, 78 episodes for which the same diagnosis was made during a previous 6-month period (because such episodes indicated potential persistent infection), and 166 episodes that were recorded during the first 6-month abstraction period for that person (because the incidence could not be determined). Overall, 816 persons accounted for 832 incident cases of bacterial diarrhea included in the stratified incidence analysis (table 3; figures 1 and 2).
Stratification of incidence rates for bacterial diarrheal illness by stage of HIV disease demonstrated significant differences between the rates of CDAD and the rates of diarrhea due to other bacteria (table 3). The rates for CDAD and for diarrhea due to other bacteria were significantly higher for persons with more advanced stages of HIV disease, particularly for persons with clinical AIDS. Among persons with clinical AIDS, the incidence rate of CDAD (9.59 cases per 1000 person-years) was almost twice that of other bacterial diarrhea (5.08 cases per 1000 person-years)
Bacterial diarrhea trends. Although not statistically significant, the overall rate of CDAD decreased from 4.7 cases per 1000 person-years in 1992 to 2.9 cases per 1000 person-years in 2002 (OR, 0.7; 95% CI, 0.4-1.1; figure 1 ). When rates of diarrhea were stratified by stage of HIV disease, only persons with clinical AIDS showed a significant decrease in the annual rate of CDAD (OR, 0.4; 95% CI, 0.2-0.7). Although the rate of CDAD appears to have started to increase between 1999 and 2002, this change was not statistically significant in any group (referent year, 1999).
The overall rate of diarrhea due to other bacterial causes decreased significantly, from 5.6 cases per 1000 person-years in 1992 to 1.9 cases per 1000 person-years in 2002 (OR, 0.3; 95% CI, 0.2-0.6; figure 2). As with CDAD, when rates were stratified by stage of HIV disease, the annual rate of diarrhea due to other bacterial causes significantly decreased only among persons with clinical AIDS (OR, 0.3; 95% CI, 0.2-0.6).
DISCUSSION
In this analysis of observational data from a large multiyear national cohort, the most common cause of bacterial diarrheal illness was C. difficile. This finding is consistent with findings from other recent studies conducted among persons with HIV infection [9, 18] . The overall incidence of bacterial diarrhea in our cohort of HIV-infected persons (7.2 cases per 1000 personyears) was at least 100-fold greater than bacterial diarrhea rates reported for the general US population [19] [20] [21] . Notably, we found that persons with more advanced HIV disease (i.e., clinical AIDS) were at significantly greater risk of developing bacterial diarrheal illness.
In contrast to our findings, some authors have reported MAC as the most common bacterial pathogen isolated from stool samples from HIV-infected persons with diarrhea [1, 22] ; however, MAC accounted for only 2% of diagnoses in our study. Notably, these studies were conducted before widespread use of effective primary MAC prophylaxis or before the introduction of HAART. These interventions have had a major impact on reducing all forms of MAC-related illness and isolation of MAC from stool samples of patients with diarrhea [23] . It is also possible that MAC may have been overestimated as a causative agent in prior studies because of the difficulty in identifying other bacterial diarrhea pathogens, such as Clostridium and Campylobacter species.
The next most common pathogens found in our study were Shigella organisms, predominantly Shigella flexneri. The presence of Shigella species (including S. flexneri) in the general population is substantially lower [20, 21] than that in our study. Although only 48% of our study participants were men who have sex with men, 75% of Shigella infections in our study occurred among persons in that group. Outbreak investigations and additional studies of Shigella sonnei and S. flexneri infections among men who have sex with men indicate that organisms from this genus can be transmitted via sexual contact [24] [25] [26] . In our study, the disproportionate number of shigellosis episodes among men who have sex with men may be related to sexual transmission, but the available data do not allow quantification of the attributable risk for this exposure versus immunosuppression due to HIV infection. Other researchers have hypothesized that an alteration in mucosal immunity may explain why rates of some bacterial infections (such as those due to Campylobacter and Salmonella organisms) are higher among persons with HIV infection than among those without HIV infection [8, 27] and that mucosal immune function is adversely affected as HIV-related immune suppression increases [28] [29] [30] .
The overall incidence of CDAD among persons with HIV infection was 4.1 cases per 1000 person-years in our study, which is considerably less than the rate of 41 cases per 1000 person-years among patients with HIV infection described by Hutin et al. [31] . The study by Hutin and colleagues was conducted before HAART became widely available and involved persons who had been hospitalized. Hospitalization is a major risk factor for developing CDAD. While hospitalized, persons with HIV infection are commonly exposed to antibiotics, another important risk factor for CDAD [9, 18, [32] [33] [34] . By comparison, persons enrolled in the ASD Project were seen in a wide range of clinical settings, and many may have been generally well and not receiving antibiotics.
During the past decade, the rates of bacterial diarrheal illness caused by Salmonella, Campylobacter, and Shigella organisms have decreased in the US general population [20, 21] ; the decrease has been attributed, in part, to improvements in safe food handling and preparation. We cannot determine the contribution of these factors to the decrease that we observed in the annual incidence rate of bacterial diarrhea. However, similar to the findings of others [10, 35] , the decrease we observed in our study population suggests that the reduction was due, in part, to the introduction of improved treatment for HIV infection. Antiretroviral-mediated suppression of HIV replication improves immune function, which leads to fewer hospitalizations and reduced antibiotic use (i.e., decreased risk for CDAD) [10, 36] .
Our study has several limitations. Although the ASD Project includes a diverse array of study sites across the country, the surveillance population may not be representative of all persons with HIV infection in the United States [11] . Our reported incidence rates for bacterial diarrhea likely represent minimum estimates, because persons with diarrhea may not have sought care; persons who sought care may not have had stool samples collected or tested; laboratory protocols were not standardized, and some organisms may not have been identified with equal likelihood; and some incident cases (e.g., recurrent episodes, episodes involving multiple types of organisms, and episodes due to E. coli) may have been excluded in our conservative analysis. We believe that persons with more severe diarrhea or advanced HIV disease would have been more likely to seek medical care and to have stool testing performed, but data to examine these issues are not available in the ASD Project. We also cannot rule out the possibility that the greater incidence of diarrhea among immunocompromised patients was also related to other factors, such as more-frequent hospitalization or greater exposure to antibiotic therapy.
The role of Yersenia, Aeromonas, and nontuberculous Mycobacterium species as diarrheal pathogens remains uncertain, especially for persons with HIV infection [12, 13] . Reanalysis after removal of cases of diarrheal illness attributed to these pathogens did not substantially change our results. An overestimate of the risk for bacterial diarrhea among persons with clinical AIDS could theoretically occur if persons with diarrhea due to Salmonella organisms were more likely to develop recurrent Salmonella septicemia as an AIDS-defining opportun-istic illness. Previous studies did not find a significant association between fecal cultures positive for Salmonella and development of recurrent Salmonella septicemia [27, 37] , and Casado et al. [37] found that recurrent Salmonella septicemia was not due to a persistent intestinal focus of salmonellosis.
Health care professionals should be aware that persons with HIV infection and progressing immunocompromise are at increased risk of developing CDAD and other bacterial diarrhea. When evaluating immunocompromised patients with diarrhea, health care professionals should have a heightened level of suspicion for CDAD. Professionals who care for men who have sex with men should also be aware of the potential for sexual transmission (through the fecal-oral route) of Shigella species [24] [25] [26] and, possibly, of other infectious causes of diarrhea. Finally, all health care professionals who treat persons infected with HIV should continue to reinforce prevention measures, such as thorough hand washing, food preparation safety, and responsible pet ownership [38, 39] .
